| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXAS | Common Stock | Options Exercise | $25,402 | +5,050 | +7.1% | $5.03* | 75,930 | 11 Jun 2021 | Direct | |
| transaction | EXAS | Common Stock | Options Exercise | $174,567 | +8,052 | +11% | $21.68 | 83,982 | 11 Jun 2021 | Direct | |
| transaction | EXAS | Common Stock | Options Exercise | $9,808 | +1,950 | +2.3% | $5.03* | 85,932 | 14 Jun 2021 | Direct | |
| transaction | EXAS | Common Stock | Sale | $358,937 | -2,945 | -3.4% | $121.88 | 82,987 | 14 Jun 2021 | Direct | F1, F2 |
| transaction | EXAS | Common Stock | Sale | $180,487 | -1,470 | -1.8% | $122.78 | 81,517 | 14 Jun 2021 | Direct | F1, F3 |
| transaction | EXAS | Common Stock | Sale | $109,368 | -885 | -1.1% | $123.58 | 80,632 | 14 Jun 2021 | Direct | F1, F4 |
| transaction | EXAS | Common Stock | Sale | $18,663 | -150 | -0.19% | $124.42 | 80,482 | 14 Jun 2021 | Direct | F1 |
| holding | EXAS | Common Stock | 4,922 | 11 Jun 2021 | Held in 401(k) Plan |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXAS | Stock Option (right to buy) | Options Exercise | $25,402 | -5,050 | -46% | $5.03* | 5,850 | 11 Jun 2021 | Common Stock | 5,050 | $5.03 | Direct | F5 |
| transaction | EXAS | Stock Option (right to buy) | Options Exercise | $174,567 | -8,052 | -27% | $21.68 | 21,948 | 11 Jun 2021 | Common Stock | 8,052 | $21.68 | Direct | F6 |
| transaction | EXAS | Stock Option (right to buy) | Options Exercise | $9,808 | -1,950 | -33% | $5.03* | 3,900 | 14 Jun 2021 | Common Stock | 1,950 | $5.03 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into in February 2021. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.37 to $122.36, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.37 to $123.11, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.23 to $123.80, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. |
| F5 | These options vested and became exercisable in full on February 28, 2020. |
| F6 | These options vested and became exercisable in full on February 23, 2021. |